From committee: Filed with the Chief Clerk pursuant to Joint Rule 56.
Summary
The bill would mandate that public, charter and (voluntarily) private schools keep at least one FDA‑approved epinephrine delivery system on site, designate trained nurses or volunteers to administer it, and set up training, notice and liability protections. It also clarifies how students may self‑administer prescribed devices with physician and parent documentation. The aim is to ensure rapid, safe treatment of severe allergic reactions in schools.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about AB 228
3 free questions a day, no accountVote
8 yes
0 no
From committee: Do pass and re-refer to Com. on APPR. (Ayes 8. Noes 0.) (March 12). Re-referred to Com. on APPR. · Mar 13, 2025
Hearings
- Appropriations Committee HearingAppropriations · May 23, 2025
- Appropriations Committee HearingAppropriations · Apr 9, 2025
- Education Committee HearingEducation · Mar 12, 2025
History
- From committee: Filed with the Chief Clerk pursuant to Joint Rule 56.
- Died pursuant to Art. IV, Sec. 10(c) of the Constitution.
- In committee: Hearing postponed by committee.
- In committee: Set, first hearing. Referred to APPR. suspense file.
- From committee: Do pass and re-refer to Com. on APPR. (Ayes 8. Noes 0.) (March 12). Re-referred to Com. on APPR.
- Referred to Com. on ED.
- From printer. May be heard in committee February 13.
- Read first time. To print.
Sponsors
- Sanchez · sponsor
- Addis
- Archuleta
- Wallis
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when AB 228 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track AB 228 freeOr ask your AI assistant about AB 228 directly:
Add to Claude, ChatGPT or Cursor